3rd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$2,220,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act, regarding all provisions - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions - H.R. 3953 / S. 1874 Title VIII Nursing Workforce Reauthorization Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 266 (119th), H.R. 6549 (119th), H.R. 5526 (119th), S. 1399 (119th), H.R. 929 (119th), S. 832 (119th), S. 1717 (119th), H.R. 6197 (119th), S. 2903 (119th), H.R. 5343 (119th), H.Res. 1301 (119th), H.R. 2214 (119th), H.R. 5509 (119th), S. 1776 (119th), H.R. 4282 (119th), H.R. 1539 (119th), H.R. 946 (119th), S. 1954 (119th), H.R. 3514 (119th), H.R. 2527 (119th), S. 864 (119th), S. 1874 (119th), H.R. 1492 (119th), H.R. 3521 (119th), H.R. 4299 (119th), H.R. 3953 (119th), H.R. 5256 (119th), H.R. 7391 (119th), H.R. 3006 (119th)

Budget/Appropriations BUD

- Issues related to stroke care

LobbyistCovered position, as disclosed
LEIF BRIERLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act, regarding all provisions Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

LobbyistCovered position, as disclosed
MATTHEW CLARKIN —
DAVID KAVANAUGH —
WENDY SUSSMAN —
TIMOTHY SWOPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Bills named: S. 2276 (119th), S. 1040 (119th), S. 2658 (119th), S. 1097 (119th), S. 1041 (119th), H.R. 3269 (119th)

Law Enforcement/Crime/Criminal Justice LAW

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding, regarding all provisions - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding, regarding all provisions

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2675 (119th), H.R. 1109 (119th)

Pharmacy PHA

- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.

LobbyistCovered position, as disclosed
AMY PELLEGRINO —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2483 (119th)

Science/Technology SCI

H.R.8413, the SECURE Data Act, regarding all provisions Issues related to - artificial intelligence - data privacy - cybersecurity - robotics

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
MEGHAN DRENAN STONE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8413 (119th)

Taxation/Internal Revenue Code TAX

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - S. 2003, the "Strengthening Benefits Plans Act", provisions on use of excess pension funds

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —
KELLY WATERS —

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2003 (119th)

Veterans VET

Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
MEGHAN DRENAN STONE —
WENDY SUSSMAN —
COLLEEN VIVALDI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

Trade (domestic/foreign) TRD

- Issues related to USMCA review and renegotiation

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
DAVID KAVANAUGH —
MEGHAN DRENAN STONE —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Defense DEF

- S.4784/H.R. 8800 National Defense Authorization Act (NDAA), regarding provision prohibiting Department of Defense (DOD) contracted companies from engaging in stock buybacks and issuing shareholder dividends absent a waiver from the Secretary

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LARRY CAMM —
DAVID KAVANAUGH —
COLLEEN VIVALDI —
FOLASHADE WILSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 4784 (119th), H.R. 8800 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.